Skip to content
  • Saturday, 15 August 2026
  • 12:12 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • 12 Practical Strategies to Drastically Reduce LLM Latency and Inference Costs in Production
Data Science & Bioinformatics

12 Practical Strategies to Drastically Reduce LLM Latency and Inference Costs in Production

Evan Lee Salim Jul 14, 2026 0

The rapid proliferation of Large Language Models (LLMs) in enterprise applications has unveiled a critical challenge: the escalating costs and…

Read More
Data Science & Bioinformatics

OpenAI Codex Revolutionizes Software Development with Five Demonstrative Projects Showcasing AI’s Practical Application Across Diverse Fields.

Evan Lee Salim Jun 17, 2026 0

The advent of sophisticated artificial intelligence models, particularly in the realm of code generation and assistance, has ushered in a…

Read More
Data Science & Bioinformatics

Practical NLP in the Browser with Transformers.js

Evan Lee Salim May 29, 2026 0

The landscape of Natural Language Processing (NLP) deployment has undergone a significant transformation, with a groundbreaking shift now enabling state-of-the-art…

Read More
Data Science & Bioinformatics

Optimizing Claude Code Token Usage: Seven Practical Strategies for Cost-Effective AI Development

Evan Lee Salim May 4, 2026 0

The integration of artificial intelligence into software development workflows, exemplified by tools like Anthropic’s Claude Code, has revolutionized productivity and…

Read More
Molecular Switch Discovery Enhances Blood Stem Cell Activation for More Effective Transplants and Gene TherapiesMultiomic and Spatial Technologies Revolutionize Understanding of Disease Progression, Paving Way for Precision MedicineApotex Acquires Cumberland Pharmaceuticals’ Branded Drug Portfolio for $100 Million, Ushering in New Era for Both CompaniesThe biotech bi-weekly: genome editing, life-extending therapeutics, an early-stage biotech hub and more
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ